Ube2ohem9
Chemically induced Allele Detail
|
Symbol: |
Ube2ohem9 |
Name: |
ubiquitin-conjugating enzyme E2O; haematopoietic 9 |
MGI ID: |
MGI:5902131 |
Synonyms: |
hem9, Ube2oE1121X |
Gene: |
Ube2o Location: Chr11:116428566-116472273 bp, - strand Genetic Position: Chr11, 81.42 cM
|
Alliance: |
Ube2ohem9 page
|
|
|
Allele Type: |
|
Chemically induced (ENU) (Null/knockout) |
Mutation: |
|
Nucleotide substitutions
|
|
|
Mutation details: This allele was identified in a screen for a metabolic and haematopoietic phenotype described as hypochromic, microcytic anemia associated with erythrocytosis using ENU-treated C57BL/6J males (G0). Sequencing identified a G to T substitution, resulting in a E1121X (changing glutamic acid to a termination codon) mutation in the Ube2o gene. The mutation causes truncation of the C-terminal 168 amino acids and is a loss-of-function mutation. No gene product (protein) is detected by western blot analysis of blood.
(J:243727)
|
|
|
|
Original: |
J:243727 Nguyen AT, et al., UBE2O remodels the proteome during terminal erythroid differentiation. Science. 2017 Aug 04;357(6350) |
All: |
1 reference(s) |
|